|
Reference
1. Rizzetto M, Canese MG, Arico S, Crivelli O, Trepo C, Bonino F, et al. Immunofluorescence detection of new antigen-antibody system (delta/anti-delta) associated to hepatitis B virus in liver and in serum of HBsAg carriers. Gut. 1977;18(12):997-1003. 2. Wu JC, Chen PJ, Kuo MY, Lee SD, Chen DS, Ting LP. Production of hepatitis delta virus and suppression of helper hepatitis B virus in a human hepatoma cell line. J Virol. 1991;65(3):1099-104. 3. Rizzetto M, Canese MG, Gerin JL, London WT, Sly DL, Purcell RH. Transmission of the hepatitis B virus-associated delta antigen to chimpanzees. J Infect Dis. 1980;141(5):590-602. 4. Krogsgaard K, Kryger P, Aldershvile J, Andersson P, Sorensen TI, Nielsen JO. Delta-infection and suppression of hepatitis B virus replication in chronic HBsAg carriers. Hepatology. 1987;7(1):42-5. 5. Wu JC, Chen TZ, Huang YS, Yen FS, Ting LT, Sheng WY, et al. Natural history of hepatitis D viral superinfection: significance of viremia detected by polymerase chain reaction. Gastroenterology. 1995;108(3):796-802. 6. Ottobrelli A, Marzano A, Smedile A, Recchia S, Salizzoni M, Cornu C, et al. Patterns of hepatitis delta virus reinfection and disease in liver transplantation. Gastroenterology. 1991;101(6):1649-55. 7. Smedile A, Farci P, Verme G, Caredda F, Cargnel A, Caporaso N, et al. Influence of delta infection on severity of hepatitis B. Lancet. 1982;2(8305):945-7. 8. Smedile A, Dentico P, Zanetti A, Sagnelli E, Nordenfelt E, Actis GC, et al. Infection with the delta agent in chronic HBsAg carriers. Gastroenterology. 1981;81(6):992-7. 9. Bonino F, Heermann KH, Rizzetto M, Gerlich WH. Hepatitis delta virus: protein composition of delta antigen and its hepatitis B virus-derived envelope. J Virol. 1986;58(3):945-50. 10. Sureau C, Guerra B, Lanford RE. Role of the large hepatitis B virus envelope protein in infectivity of the hepatitis delta virion. J Virol. 1993;67(1):366-72. 11. Ryu WS, Netter HJ, Bayer M, Taylor J. Ribonucleoprotein complexes of hepatitis delta virus. J Virol. 1993;67(6):3281-7. 12. Lin BC, Defenbaugh DA, Casey JL. Multimerization of Hepatitis Delta Antigen Is a Critical Determinant of RNA Binding Specificity. Journal of Virology. 2010;84(3):1406-13. 13. Wang KS, Choo QL, Weiner AJ, Ou JH, Najarian RC, Thayer RM, et al. Structure, sequence and expression of the hepatitis delta (delta) viral genome. Nature. 1986;323(6088):508-14. 14. Griffin BL, Chasovskikh S, Dritschilo A, Casey JL. Hepatitis delta antigen requires a flexible quasi-double-stranded RNA structure to bind and condense hepatitis delta virus RNA in a ribonucleoprotein complex. J Virol. 2014;88(13):7402-11. 15. Gudima S, Chang J, Moraleda G, Azvolinsky A, Taylor J. Parameters of human hepatitis delta virus genome replication: the quantity, quality, and intracellular distribution of viral proteins and RNA. J Virol. 2002;76(8):3709-19. 16. Defenbaugh DA, Johnson M, Chen R, Zheng YY, Casey JL. Hepatitis delta antigen requires a minimum length of the hepatitis delta virus unbranched rod RNA structure for binding. J Virol. 2009;83(9):4548-56. 17. Kuo MY, Goldberg J, Coates L, Mason W, Gerin J, Taylor J. Molecular cloning of hepatitis delta virus RNA from an infected woodchuck liver: sequence, structure, and applications. J Virol. 1988;62(6):1855-61. 18. Chen PJ, Kalpana G, Goldberg J, Mason W, Werner B, Gerin J, et al. Structure and replication of the genome of the hepatitis delta virus. Proc Natl Acad Sci U S A. 1986;83(22):8774-8. 19. Ferre-D'Amare AR, Zhou K, Doudna JA. Crystal structure of a hepatitis delta virus ribozyme. Nature. 1998;395(6702):567-74. 20. Sharmeen L, Kuo MY, Dinter-Gottlieb G, Taylor J. Antigenomic RNA of human hepatitis delta virus can undergo self-cleavage. J Virol. 1988;62(8):2674-9. 21. Nie X, Chang J, Taylor JM. Alternative processing of hepatitis delta virus antigenomic RNA transcripts. J Virol. 2004;78(9):4517-24. 22. Weiner AJ, Choo QL, Wang KS, Govindarajan S, Redeker AG, Gerin JL, et al. A Single Antigenomic Open Reading Frame of the Hepatitis Delta Virus Encodes the Epitope(S) of Both Hepatitis Delta Antigen Polypeptides P24-Delta and P27-Delta. Journal of Virology. 1988;62(2):594-9. 23. Casey JL, Bergmann KF, Brown TL, Gerin JL. Structural requirements for RNA editing in hepatitis delta virus: evidence for a uridine-to-cytidine editing mechanism. Proc Natl Acad Sci U S A. 1992;89(15):7149-53. 24. Casey JL. Control of ADAR1 editing of hepatitis delta virus RNAs. Curr Top Microbiol Immunol. 2012;353:123-43. 25. Kuo MY, Chao M, Taylor J. Initiation of replication of the human hepatitis delta virus genome from cloned DNA: role of delta antigen. J Virol. 1989;63(5):1945-50. 26. Chang FL, Chen PJ, Tu SJ, Wang CJ, Chen DS. The Large Form of Hepatitis-Delta Antigen Is Crucial for Assembly of Hepatitis-Delta Virus. P Natl Acad Sci USA. 1991;88(19):8490-4. 27. Chao M, Hsieh SY, Taylor J. Role of two forms of hepatitis delta virus antigen: evidence for a mechanism of self-limiting genome replication. J Virol. 1990;64(10):5066-9. 28. Ishikawa M, Meshi T, Ohno T, Okada Y, Sano T, Ueda I, et al. A revised replication cycle for viroids: the role of longer than unit length RNA in viroid replication. Mol Gen Genet. 1984;196(3):421-8. 29. Branch AD, Robertson HD. A replication cycle for viroids and other small infectious RNA's. Science. 1984;223(4635):450-5. 30. Schulze A, Gripon P, Urban S. Hepatitis B virus infection initiates with a large surface protein-dependent binding to heparan sulfate proteoglycans. Hepatology. 2007;46(6):1759-68. 31. Leistner CM, Gruen-Bernhard S, Glebe D. Role of glycosaminoglycans for binding and infection of hepatitis B virus. Cell Microbiol. 2008;10(1):122-33. 32. Longarela OL, Schmidt TT, Schoeneweis K, Romeo R, Wedemeyer H, Urban S, et al. Proteoglycans Act as Cellular Hepatitis Delta Virus Attachment Receptors. Plos One. 2013;8(3). 33. Abou-Jaoude G, Sureau C. Entry of hepatitis delta virus requires the conserved cysteine residues of the hepatitis B virus envelope protein antigenic loop and is blocked by inhibitors of thiol-disulfide exchange. Journal of Virology. 2007;81(23):13057-66. 34. Li W. The hepatitis B virus receptor. Annu Rev Cell Dev Biol. 2015;31:125-47. 35. Ni Y, Lempp FA, Mehrle S, Nkongolo S, Kaufman C, Falth M, et al. Hepatitis B and D Viruses Exploit Sodium Taurocholate Co-transporting Polypeptide for Species-Specific Entry into Hepatocytes. Gastroenterology. 2014;146(4):1070-U301. 36. Yan H, Zhong GC, Xu GW, He WH, Jing ZY, Gao ZC, et al. Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus. Elife. 2012;1. 37. Cooper A, Shaul Y. Clathrin-mediated endocytosis and lysosomal cleavage of hepatitis B virus capsid-like core particles. J Biol Chem. 2006;281(24):16563-9. 38. Macovei A, Radulescu C, Lazar C, Petrescu S, Durantel D, Dwek RA, et al. Hepatitis B Virus Requires Intact Caveolin-1 Function for Productive Infection in HepaRG Cells. Journal of Virology. 2010;84(1):243-53. 39. Huang HC, Chen CC, Chang WC, Tao MH, Huang C. Entry of Hepatitis B Virus into Immortalized Human Primary Hepatocytes by Clathrin-Dependent Endocytosis. Journal of Virology. 2012;86(17):9443-53. 40. Xia YP, Yeh CT, Ou JH, Lai MM. Characterization of nuclear targeting signal of hepatitis delta antigen: nuclear transport as a protein complex. J Virol. 1992;66(2):914-21. 41. Chang MF, Chang SC, Chang CI, Wu K, Kang HY. Nuclear localization signals, but not putative leucine zipper motifs, are essential for nuclear transport of hepatitis delta antigen. J Virol. 1992;66(10):6019-27. 42. Flores R, Grubb D, Elleuch A, Nohales MA, Delgado S, Gago S. Rolling-circle replication of viroids, viroid-like satellite RNAs and hepatitis delta virus: variations on a theme. RNA Biol. 2011;8(2):200-6. 43. Maul GG. Nuclear domain 10, the site of DNA virus transcription and replication. Bioessays. 1998;20(8):660-7. 44. Lai MM. The molecular biology of hepatitis delta virus. Annu Rev Biochem. 1995;64:259-86. 45. Chang J, Nie X, Chang HE, Han Z, Taylor J. Transcription of hepatitis delta virus RNA by RNA polymerase II. J Virol. 2008;82(3):1118-27. 46. Tseng CH, Lai MM. Hepatitis delta virus RNA replication. Viruses. 2009;1(3):818-31. 47. Ke A, Zhou K, Ding F, Cate JH, Doudna JA. A conformational switch controls hepatitis delta virus ribozyme catalysis. Nature. 2004;429(6988):201-5. 48. Reid CE, Lazinski DW. A host-specific function is required for ligation of a wide variety of ribozyme-processed RNAs. Proc Natl Acad Sci U S A. 2000;97(1):424-9. 49. Hsieh SY, Chao M, Coates L, Taylor J. Hepatitis delta virus genome replication: a polyadenylated mRNA for delta antigen. J Virol. 1990;64(7):3192-8. 50. Hsieh SY, Taylor J. Regulation of polyadenylation of hepatitis delta virus antigenomic RNA. J Virol. 1991;65(12):6438-46. 51. Taylor JM. Human hepatitis delta virus: an agent with similarities to certain satellite RNAs of plants. Curr Top Microbiol Immunol. 1999;239:107-22. 52. Lai MMC. RNA replication without RNA-dependent RNA polymerase: Surprises from hepatitis delta virus. Journal of Virology. 2005;79(13):7951-8. 53. Chen R, Linnstaedt SD, Casey JL. RNA editing and its control in hepatitis delta virus replication. Viruses. 2010;2(1):131-46. 54. Hartwig D, Schutte C, Warnecke J, Dorn I, Hennig H, Kirchner H, et al. The large form of ADAR 1 is responsible for enhanced hepatitis delta virus RNA editing in interferon-alpha-stimulated host cells. J Viral Hepat. 2006;13(3):150-7. 55. Polson AG, Bass BL, Casey JL. RNA editing of hepatitis delta virus antigenome by dsRNA-adenosine deaminase. Nature. 1996;380(6573):454-6. 56. Wong SK, Lazinski DW. Replicating hepatitis delta virus RNA is edited in the nucleus by the small form of ADAR1. Proc Natl Acad Sci U S A. 2002;99(23):15118-23. 57. Huang WH, Chen CW, Wu HL, Chen PJ. Post-translational modification of delta antigen of hepatitis D virus. Curr Top Microbiol Immunol. 2006;307:91-112. 58. Zuccola HJ, Rozzelle JE, Lemon SM, Erickson BW, Hogle JM. Structural basis of the oligomerization of hepatitis delta antigen. Structure. 1998;6(7):821-30. 59. Cornillez-Ty CT, Lazinski DW. Determination of the multimerization state of the hepatitis delta virus antigens in vivo. J Virol. 2003;77(19):10314-26. 60. Macnaughton TB, Lai MM. Genomic but not antigenomic hepatitis delta virus RNA is preferentially exported from the nucleus immediately after synthesis and processing. J Virol. 2002;76(8):3928-35. 61. Wang YH, Chang SC, Huang C, Li YP, Lee CH, Chang MF. Novel nuclear export signal-interacting protein, NESI, critical for the assembly of hepatitis delta virus. J Virol. 2005;79(13):8113-20. 62. Lee CH, Chang SC, Wu CH, Chang MF. A novel chromosome region maintenance 1-independent nuclear export signal of the large form of hepatitis delta antigen that is required for the viral assembly. J Biol Chem. 2001;276(11):8142-8. 63. Alves C, Freitas N, Cunha C. Characterization of the nuclear localization signal of the hepatitis delta virus antigen. Virology. 2008;370(1):12-21. 64. Chang MF, Chen CH, Lin SL, Chen CJ, Chang SC. Functional domains of delta antigens and viral RNA required for RNA packaging of hepatitis delta virus. J Virol. 1995;69(4):2508-14. 65. Glenn JS, Watson JA, Havel CM, White JM. Identification of a prenylation site in delta virus large antigen. Science. 1992;256(5061):1331-3. 66. O'Malley B, Lazinski DW. Roles of carboxyl-terminal and farnesylated residues in the functions of the large hepatitis delta antigen. J Virol. 2005;79(2):1142-53. 67. Komla-Soukha I, Sureau C. A tryptophan-rich motif in the carboxyl terminus of the small envelope protein of hepatitis B virus is central to the assembly of hepatitis delta virus particles. J Virol. 2006;80(10):4648-55. 68. Shih HH, Shih C, Wang HW, Su CW, Sheen IJ, Wu JC. Pro-205 of large hepatitis delta antigen and Pro-62 of major hepatitis B surface antigen influence the assembly of different genotypes of hepatitis D virus. J Gen Virol. 2010;91(Pt 4):1004-12. 69. Huang C, Chang SC, Yu IC, Tsay YG, Chang MF. Large hepatitis delta antigen is a novel clathrin adaptor-like protein. J Virol. 2007;81(11):5985-94. 70. Huang C, Chang SC, Yang HC, Chien CL, Chang MF. Clathrin-mediated post-Golgi membrane trafficking in the morphogenesis of hepatitis delta virus. J Virol. 2009;83(23):12314-24. 71. Li YJ, Stallcup MR, Lai MMC. Hepatitis delta virus antigen is methylated at arginine residues, and methylation regulates subcellular localization and RNA replication. Journal of Virology. 2004;78(23):13325-34. 72. Mu JJ, Tsay YG, Juan LJ, Fu TF, Huang WH, Chen DS, et al. The small delta antigen of hepatitis delta virus is an acetylated protein and acetylation of lysine 72 may influence its cellular localization and viral RNA synthesis. Virology. 2004;319(1):60-70. 73. Yeh TS, Lo SJ, Chen PJ, Lee YH. Casein kinase II and protein kinase C modulate hepatitis delta virus RNA replication but not empty viral particle assembly. J Virol. 1996;70(9):6190-8. 74. Hong SY, Chen PJ. Phosphorylation of serine 177 of the small hepatitis delta antigen regulates viral antigenomic RNA replication by interacting with the processive RNA polymerase II. J Virol. 2010;84(3):1430-8. 75. Mu JJ, Chen DS, Chen PJ. The conserved serine 177 in the delta antigen of hepatitis delta virus is one putative phosphorylation site and is required for efficient viral RNA replication. Journal of Virology. 2001;75(19):9087-95. 76. Tseng CH, Cheng TS, Shu CY, Jeng KS, Lai MM. Modification of small hepatitis delta virus antigen by SUMO protein. J Virol. 2010;84(2):918-27. 77. Otto JC, Casey PJ. The hepatitis delta virus large antigen is farnesylated both in vitro and in animal cells. J Biol Chem. 1996;271(9):4569-72. 78. Hwang SB, Lai MM. Isoprenylation masks a conformational epitope and enhances trans-dominant inhibitory function of the large hepatitis delta antigen. J Virol. 1994;68(5):2958-64. 79. Lee CZ, Chen PJ, Lai MM, Chen DS. Isoprenylation of large hepatitis delta antigen is necessary but not sufficient for hepatitis delta virus assembly. Virology. 1994;199(1):169-75. 80. Hwang SB, Lai MM. Isoprenylation mediates direct protein-protein interactions between hepatitis large delta antigen and hepatitis B virus surface antigen. J Virol. 1993;67(12):7659-62. 81. Lee CM, Bih FY, Chao YC, Govindarajan S, Lai MM. Evolution of hepatitis delta virus RNA during chronic infection. Virology. 1992;188(1):265-73. 82. Le Gal F, Gault E, Ripault MP, Serpaggi J, Trinchet JC, Gordien E, et al. Eighth major clade for hepatitis delta virus. Emerg Infect Dis. 2006;12(9):1447-50. 83. Wu JC, Chiang TY, Shiue WK, Wang SY, Sheen IJ, Huang YH, et al. Recombination of hepatitis D virus RNA sequences and its implications. Mol Biol Evol. 1999;16(11):1622-32. 84. Wu JC, Chen CM, Sheen IJ, Lee SD, Tzeng HM, Choo KB. Evidence of transmission of hepatitis D virus to spouses from sequence analysis of the viral genome. Hepatology. 1995;22(6):1656-60. 85. Chao YC, Chang MF, Gust I, Lai MM. Sequence conservation and divergence of hepatitis delta virus RNA. Virology. 1990;178(2):384-92. 86. Wu JC, Chiang TY, Sheen IJ. Characterization and phylogenetic analysis of a novel hepatitis D virus strain discovered by restriction fragment length polymorphism analysis. J Gen Virol. 1998;79 ( Pt 5):1105-13. 87. Wu JC, Choo KB, Chen CM, Chen TZ, Huo TI, Lee SD. Genotyping of hepatitis D virus by restriction-fragment length polymorphism and relation to outcome of hepatitis D. Lancet. 1995;346(8980):939-41. 88. Farci P, Roskams T, Chessa L, Peddis G, Mazzoleni AP, Scioscia R, et al. Long-term benefit of interferon alpha therapy of chronic hepatitis D: regression of advanced hepatic fibrosis. Gastroenterology. 2004;126(7):1740-9. 89. McNair AN, Cheng D, Monjardino J, Thomas HC, Kerr IM. Hepatitis delta virus replication in vitro is not affected by interferon-alpha or -gamma despite intact cellular responses to interferon and dsRNA. J Gen Virol. 1994;75 ( Pt 6):1371-8. 90. Oehler N, Volz T, Bhadra OD, Kah J, Allweiss L, Giersch K, et al. Binding of hepatitis B virus to its cellular receptor alters the expression profile of genes of bile acid metabolism. Hepatology. 2014;60(5):1483-93. 91. Bordier BB, Ohkanda J, Liu P, Lee SY, Salazar FH, Marion PL, et al. In vivo antiviral efficacy of prenylation inhibitors against hepatitis delta virus. J Clin Invest. 2003;112(3):407-14. 92. Bordier BB, Marion PL, Ohashi K, Kay MA, Greenberg HB, Casey JL, et al. A prenylation inhibitor prevents production of infectious hepatitis delta virus particles. J Virol. 2002;76(20):10465-72. 93. Shi Y, Massague J. Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell. 2003;113(6):685-700. 94. Bedossa P, Peltier E, Terris B, Franco D, Poynard T. Transforming growth factor-beta 1 (TGF-beta 1) and TGF-beta 1 receptors in normal, cirrhotic, and neoplastic human livers. Hepatology. 1995;21(3):760-6. 95. Castilla A, Prieto J, Fausto N. Transforming growth factors beta 1 and alpha in chronic liver disease. Effects of interferon alfa therapy. N Engl J Med. 1991;324(14):933-40. 96. Harada K, Shiota G, Kawasaki H. Transforming growth factor-alpha and epidermal growth factor receptor in chronic liver disease and hepatocellular carcinoma. Liver. 1999;19(4):318-25. 97. Zavadil J, Bottinger EP. TGF-beta and epithelial-to-mesenchymal transitions. Oncogene. 2005;24(37):5764-74. 98. Choi SH, Jeong SH, Hwang SB. Large hepatitis delta antigen modulates transforming growth factor-beta signaling cascades: implication of hepatitis delta virus-induced liver fibrosis. Gastroenterology. 2007;132(1):343-57. 99. Nguyen LN, Furuya MH, Wolfraim LA, Nguyen AP, Holdren MS, Campbell JS, et al. Transforming growth factor-beta differentially regulates oval cell and hepatocyte proliferation. Hepatology. 2007;45(1):31-41. 100. Singh A, Settleman J. EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer. Oncogene. 2010;29(34):4741-51. 101. Kitisin K, Ganesan N, Tang Y, Jogunoori W, Volpe EA, Kim SS, et al. Disruption of transforming growth factor-beta signaling through beta-spectrin ELF leads to hepatocellular cancer through cyclin D1 activation. Oncogene. 2007;26(50):7103-10. 102. Choi SS, Diehl AM. Epithelial-to-mesenchymal transitions in the liver. Hepatology. 2009;50(6):2007-13. 103. Lamouille S, Derynck R. Cell size and invasion in TGF-beta-induced epithelial to mesenchymal transition is regulated by activation of the mTOR pathway. J Cell Biol. 2007;178(3):437-51. 104. Yang MH, Chen CL, Chau GY, Chiou SH, Su CW, Chou TY, et al. Comprehensive analysis of the independent effect of twist and snail in promoting metastasis of hepatocellular carcinoma. Hepatology. 2009;50(5):1464-74. 105. Quintao EC. [Statins in hypercholesterolemia treatment]. Rev Assoc Med Bras (1992). 1994;40(1):50-8. 106. Istvan ES, Deisenhofer J. Structural mechanism for statin inhibition of HMG-CoA reductase. Science. 2001;292(5519):1160-4. 107. Greenwood J, Steinman L, Zamvil SS. Statin therapy and autoimmune disease: from protein prenylation to immunomodulation. Nat Rev Immunol. 2006;6(5):358-70. 108. Cao Z, Fan-Minogue H, Bellovin DI, Yevtodiyenko A, Arzeno J, Yang Q, et al. MYC phosphorylation, activation, and tumorigenic potential in hepatocellular carcinoma are regulated by HMG-CoA reductase. Cancer Res. 2011;71(6):2286-97. 109. Hindler K, Cleeland CS, Rivera E, Collard CD. The role of statins in cancer therapy. Oncologist. 2006;11(3):306-15. 110. Tsan YT, Lee CH, Wang JD, Chen PC. Statins and the risk of hepatocellular carcinoma in patients with hepatitis B virus infection. J Clin Oncol. 2012;30(6):623-30. 111. Tsan YT, Lee CH, Ho WC, Lin MH, Wang JD, Chen PC. Statins and the risk of hepatocellular carcinoma in patients with hepatitis C virus infection. J Clin Oncol. 2013;31(12):1514-21. 112. Bonovas S, Nikolopoulos G, Sitaras NM. Statins and reduced risk of hepatocellular carcinoma in patients with hepatitis C virus infection: further evidence is warranted. J Clin Oncol. 2013;31(32):4160. 113. Kah J, Wustenberg A, Keller AD, Sirma H, Montalbano R, Ocker M, et al. Selective induction of apoptosis by HMG-CoA reductase inhibitors in hepatoma cells and dependence on p53 expression. Oncol Rep. 2012;28(3):1077-83. 114. Williams V, Brichler S, Radjef N, Lebon P, Goffard A, Hober D, et al. Hepatitis delta virus proteins repress hepatitis B virus enhancers and activate the alpha/beta interferon-inducible MxA gene. J Gen Virol. 2009;90(Pt 11):2759-67.
|